Pancreatic duct stent placement prevents post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction but normal manometry results

Gastrointestinal Endoscopy

Volumn 67, Issue 2, 2008, Pages 255-261

  Saad, Abdo M ^a   Fogel, Evan L ^a   McHenry, Lee ^a   Watkins, James L ^a   Sherman, Stuart ^a   Lazzell Pannell, Laura ^a   Lehman, Glen A ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MANOMETRY; PANCREATIC DUCT STENT; PANCREATITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SPHINCTEROTOMY; STENT; VATER PAPILLA STENOSIS;

ADULT; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MANOMETRY; PANCREATIC DUCTS; PANCREATITIS; RETROSPECTIVE STUDIES; RISK FACTORS; SPHINCTER OF ODDI DYSFUNCTION; STENTS; TIME FACTORS;

EID: 38349191724     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2007.06.022     Document Type: Article

References (34)

1. Sarner M., and Cotton P.B. Classification of pancreatitis. Gut 25 (1984) 756-759
2. Cotton P.B., Lehman G., Vennes J., et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 37 (1991) 383-393
3. Freeman M., DiSario J.A., Nelson D.B., et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 54 (2001) 425-434
4. Tarnasky P., Cunningham J., Cotton P., et al. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy 29 (1997) 252-257
5. Sherman S., Ruffolo T.A., Hawes R.H., et al. Complications of endoscopic sphincterotomy: a prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts. Gastroenterology 101 (1991) 1068-1075
6. Fogel E.L., Eversman D., Jamidar P., et al. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 34 (2002) 280-285
7. Tarnasky P.R., Palesch Y.Y., Cunningham J.T., et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 115 (1998) 1518-1524
8. Elton E., Howell D.A., Parsons W.G., et al. Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique. Gastrointest Endosc 47 (1998) 240-249
9. Patel R., Tarnasky P., Hennessy W.S., et al. Does stenting after pancreatic sphincterotomy reduce post-ERCP pancreatitis in patients with prior biliary sphincterotomy? Preliminary results of a prospective randomized trial. [abstract]. Gastrointest Endosc 49 (1999) AB80
10. Aizawa T., and Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointest Endosc 54 (2001) 209-213
11. Fazel A., Quadri A., Catalano M.F., et al. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 57 (2003) 291-294
12. Freeman M.L., Overby C., and Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 59 (2004) 8-14
13. Sherman S., Earle D.T., Bucksot L., et al. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy (ES)-induced pancreatitis? A final analysis of a randomized prospective study. [abstract]. Gastrointest Endosc 43 (1996) A489
14. Smithline A., Silverman W., Rogers D., et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 39 (1993) 652-657
15. Vandervoort J., Soetikno R.M., Montes H., et al. Accuracy and complication rate of brush cytology from bile duct versus pancreatic duct. Gastrointest Endosc 49 (1999) 322-327
16. Norton I.D., Gostout C.J., Baron T.H., et al. Safety and outcome of endoscopic snare excision of the major duodenal papilla. Gastrointest Endosc 56 (2002) 239-243
17. Catalano M.F., Linder J.D., Chak A., et al. Endoscopic management of adenoma of the major duodenal papilla. Gastrointest Endosc 59 (2004) 225-232
18. Singh P., Das A., Isenberg G., et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc 60 (2004) 544-550
19. Cotton P., Mauldin P.D., Romagnuolo J., et al. The incidence of pancreatitis after ERCP/manometry has fallen with the increasing use of temporary pancreatic stents: experience of 2861 patients over 10 years. [abstract]. Gastrointest Endosc 61 (2005) AB190
20. Fogel E.L., Sherman S., Watkins J.L., et al. Pancreatitis following ERCP at a large tertiary referral center: are we making any progress?. [abstract]. Gastrointest Endosc 61 (2005) AB191
21. Elmi F., and Silverman W. Routine prophylactic pancreatic duct mini stents (PDMS) reduce the incidence of post ERCP pancreatitis (PEP) in patients undergoing sphincter of Oddi manometry (SOM) where pancreatic cannulation has occurred. [abstract]. Gastrointest Endosc 55 (2002) AB198
22. Freeman M.L., Nelson D.B., Sherman S., et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 335 (1996) 909-918
23. Masci E., Toti G., Mariani A., et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 96 (2001) 417-423
24. Loperfido S., Angelini G., Benedetti G., et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 48 (1998) 1-10
25. Mehta S.N., Pavone E., Barkun J.S., et al. Predictors of post-ERCP complications in patients with suspected choledocholithiasis. Endoscopy 30 (1998) 457-463
26. Cheng C.L., Sherman S., Watkins J.L., et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 101 (2006) 139-147
27. Christoforidis E., Goulimaris I., and Kanellos I. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors. Endoscopy 34 (2002) 286-292
28. Rabenstein T., Schneider H.T., Bulling D., et al. Analysis of the risk factors associated with endoscopic sphincterotomy techniques: preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low-dose anticoagulation treatment. Endoscopy 32 (2000) 10-19
29. Vandervoort J., Soetikno R.M., Tham T.C.K., et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 56 (2002) 652-656
30. Friedland S., Soetikno R.M., Vandervoort J., et al. Bedside scoring system to predict the risk of developing pancreatitis following ERCP. Endoscopy 34 (2002) 483-488
31. Andriulli A., Clemente R., Solmi L., et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 56 (2002) 488-495
32. Freeman M.L., and Guda N.M. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 59 (2004) 845-864
33. Cheon Y.K., Cho K.B., Watkins J.L., et al. Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification. Gastrointest Endosc 65 (2007) 385-393
34. Rashdan A., Fogel E.L., McHenry L., et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2 (2004) 322-329